SAN DIEGO – ResMed has announced that the U.S. International Trade Commission has accepted its request to investigate alleged infringement of its patented technology by Chinese manufacturer BMC Medical and its U.S. distributor, 3B Medical.
Heartland Advisors has picked up 88,747 additional shares of Invacare stock, the firm disclosed in a report filed with the SEC on May 3. Heartland Advisors now holds about 3.6 million shares valued at about $39.95 million.
SAN DIEGO – It’s still early days for recent acquisitions to impact ResMed’s financial results, but Inova Technologies helped to boost the company’s revenues by 2% in the third quarter of fiscal year 2016.
SAN DIEGO – ResMed reported revenues of $453.9 million for the three months ended March 31, 2016, a 7% increase compared to the same period in 2015. Net income for the quarter was $88.5 million, a 3% decrease compared to the same period in 2015.